Preparation of125I-Lanreotide and its biodistribution in murine model of melanoma
β Scribed by U. Pandey; A. Mukherjee; G. Samuel; S. Banerjee; H. D. Sarma; M. Venkatesh
- Publisher
- Springer
- Year
- 2007
- Tongue
- English
- Weight
- 86 KB
- Volume
- 275
- Category
- Article
- ISSN
- 1588-2780
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract This paper addresses the development of a new radiopharmaceutical for cancer imaging and therapy. The optimization of the labeling conditions of thymidine analogue, melphalan, with^125^I is described. High radiochemical yield 96.8% was obtained by reacting 0.2βmg melphalan with ^125^I i
Fifteen patients with or suspected of having ovarian carcinoma were injected intravenously (i.v.) or intraperitoneally (i.p+) with t3tl-labelled OC 125 F(ab')z. Radioimmunoscintigraphy after i.v. injection revealed 50% of the tumor sites. After i.p. injection all tumor sites were visualized, except